
SOPHiA GENETICS Initiates Public Offering of Ordinary Shares
SOPHiA GENETICS has launched a proposed underwritten public offering of its ordinary shares, signaling a new capital-raising effort for the AI-driven precision medicine firm. The company plans to grant underwriters a 30-day option to purchase up to an additional 15% of the shares offered to satisfy potential market demand.



,_3rd_Street_and_Locust_Street,_Harrisburg,_PA_-_52441722973.jpg)





















